In other words, our data support the view that “Not all forms of MASLD were created equal” [7] and that metabolic syndrome-related MASLD has a greater impact on the aortic stiffening and early carotid atherosclerosis as compared to the PNPLA3-related form. This evidence concerns the gene PNPLA3 and carotid atherosclerosis.